AdaptHealth (AHCO) Competitors

AdaptHealth presently has a consensus target price of $10.14, indicating a potential upside of 81.12%. Given AdaptHealth's stronger consensus rating and higher possible upside, equities analysts clearly believe AdaptHealth is more favorable than 111.

In the previous week, 111 had 4 more articles in the media than AdaptHealth. MarketBeat recorded 4 mentions for 111 and 0 mentions for AdaptHealth. 111's average media sentiment score of 0.15 beat AdaptHealth's score of 0.00 indicating that 111 is being referred to more favorably in the news media.

82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 21.3% of 111 shares are owned by institutional investors. 2.0% of AdaptHealth shares are owned by insiders. Comparatively, 43.9% of 111 shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

AdaptHealth has a beta of 1.42, suggesting that its share price is 42% more volatile than the broader market. Comparatively, 111 has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market.

111 has higher revenue and earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than 111, indicating that it is currently the more affordable of the two stocks.

111 has a net margin of -1.01% compared to AdaptHealth's net margin of -7.07%. AdaptHealth's return on equity of 3.36% beat 111's return on equity.

AdaptHealth has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market. Comparatively, Wellgistics Health has a beta of -3.51, indicating that its share price is 451% less volatile than the broader market.

AdaptHealth has a net margin of -7.07% compared to Wellgistics Health's net margin of -1,100.16%. AdaptHealth's return on equity of 3.36% beat Wellgistics Health's return on equity.

82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are owned by institutional investors. 2.0% of AdaptHealth shares are owned by company insiders. Comparatively, 29.1% of Wellgistics Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

AdaptHealth presently has a consensus price target of $10.14, indicating a potential upside of 81.12%. Given AdaptHealth's stronger consensus rating and higher probable upside, research analysts plainly believe AdaptHealth is more favorable than Wellgistics Health.

AdaptHealth has higher revenue and earnings than Wellgistics Health. AdaptHealth is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks.

In the previous week, Wellgistics Health had 2 more articles in the media than AdaptHealth. MarketBeat recorded 2 mentions for Wellgistics Health and 0 mentions for AdaptHealth. Wellgistics Health's average media sentiment score of 0.28 beat AdaptHealth's score of 0.00 indicating that Wellgistics Health is being referred to more favorably in the news media.

In the previous week, Ridgetech had 1 more articles in the media than AdaptHealth. MarketBeat recorded 1 mentions for Ridgetech and 0 mentions for AdaptHealth. Ridgetech's average media sentiment score of 0.37 beat AdaptHealth's score of 0.00 indicating that Ridgetech is being referred to more favorably in the media.

45.3% of Ridgetech shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 22.6% of Ridgetech shares are owned by company insiders. Comparatively, 2.0% of AdaptHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

AdaptHealth has a consensus price target of $10.14, suggesting a potential upside of 81.12%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than Ridgetech.

Ridgetech has a beta of -0.09, indicating that its stock price is 109% less volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.42, indicating that its stock price is 42% more volatile than the broader market.

Ridgetech has a net margin of 0.00% compared to AdaptHealth's net margin of -7.07%. AdaptHealth's return on equity of 3.36% beat Ridgetech's return on equity.

Ridgetech has higher earnings, but lower revenue than AdaptHealth.

82.7% of AdaptHealth shares are held by institutional investors. 2.0% of AdaptHealth shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than AdaptHealth.

In the previous week, AdaptHealth's average media sentiment score of 0.00 equaled Hong Kong Pharma Digital Technology'saverage media sentiment score.

AdaptHealth has a beta of 1.42, suggesting that its share price is 42% more volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.57, suggesting that its share price is 157% more volatile than the broader market.

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to AdaptHealth's net margin of -7.07%. AdaptHealth's return on equity of 3.36% beat Hong Kong Pharma Digital Technology's return on equity.

AdaptHealth currently has a consensus target price of $10.14, suggesting a potential upside of 81.12%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than Hong Kong Pharma Digital Technology.